Zusammenfassung
5-FU ist ein Pyrimidin Antagonist. Die Strukturformel (Abb.16.1) ist der Formel von Uracil ähnlich mit Ausnahme davon, dass sich in Position C5 ein F-Atom findet. Es handelt sich um ein weißes, kristallines Pulver; wenig löslich in Wasser, schwer löslich in Ethanol, praktisch unlöslich in Ether.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abiko Y, Tomikawa M, Shimizu M (1969) Enzymatic conversion of pantothenylalcohol to pantothenic acid. J Vitamin 15: 59–69
Amer M, Metwalli M (1998) Topical hydroquinone in the treatment of some hyperpigmentary disorders. Int J Dermatol 37: 433–453
Anderson DC and the Scandinavian and Middle-Eastern topical Minoxidil Study Group (1988) Topical minoxidil in androgenetic alopecia - Scandinavian and middle east experience. Int J Dermatol 27: 447–451
Anheller JE, Hellgren L, Karlstam B, Vincent J (1989) Biochemical and biological profile of a new enzyme preparation from antarctic krill (E superba) suitable for debridement of ulcerative lesions. Arch Dermatol Res 281: 105–110
Bamujally AJA, Judodihardja H, Gonzalez M, Varma S, Wilson H, Marks R, Anstey A (1998) Treatment of chronic plaque psoriasis with photodynamic therapy. Br J Dermatol 139 Suppl 51: 96–97
Barber ED, Hill T, Schum DB (1995) The percutaneous absorption of hydroquinone (HQ) through rat and human skin in vitro. Toxicol Lett 80: 167–172
Becker S (1997) Eigenherstellung in der Krankenhausapotheke. Beispiele aus dem Bereich der Dermatologie, Intensiv-and Hautpflege. Krankenhauspharmazie 18: 116–133
Bernd A, Jackel C, Dold K, Görmar F, Theilig C, Breuer M, Ramirez-Bosca A, Bereiter-Hahn J, Holzmann H (1994) Effect of minoxidil on the mobility and differentiation of cultivated human keratinocytes. Arzneimittelforschung 44: 137–140
Boehncke WH, Sterry W, Kaufmann R (1994) Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 343: 801
Boer EM de, Bezemer PD, Bruynzeel DP, Nieboer C (1988) Does topical minoxidil increase skin blood flow? A laser doppler flowmetry study. Acta Derm Venereol (Stockh) 68: 271–274
Bose SK, Ortonne JP (1994) Pigmentation: Dyschromia In: Baron R, Maibach HI (eds). Cosmetic Dermatology. Dunitz Verlag, pp 277–289
Breza Th, Taylor JR, Eaglstein HW (1976) Noninflammatory destruction of actinic keratoses by fluorouracil. Arch Dermatol 112: 1256–1258
Brincat M, Versi E, O’Dowd T, Moniz CF, Magos A, Kabalan S, Studd JW (1987) Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitas 9: 1–5
Burlet E (1946) Die percutane Resorption von Panthenol (3 - [2’,4’-Dioxy-3’,3’-dimethyl-bu-tyryl]-aminopropanol). Z Vitaminforsch 26: 92–97
Cameron ST, Critchley HOD, Glasier AF, Williams AR, Baird DT (1997) Continuous transdermal oestrogen and interrupted progestogen as a novel bleed free regimen of hormone replacement therapy for postmenopausal women. Br J Obstret Gynaecol 104: 1184–1190
Chiang CM, Flynn GL, Weiner ND, Szpunar GJ (1989a) Bioavailability assessment of topical delivery systems: effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations. Int J Pharm 55: 229–236
Chiang CM, Flynn GL, Weiner ND, Addicks WJ, Szpunar GJ (1989b) Bioavailability assessment of topical delivery systems: in vitro delivery of minoxidil from prototypical semi-solid formulations. Int J Pharm 49: 109–114
Clifton MM, Bayer Garner JB, Kohlers, Smoller BR (1999) Immunohistochemical evaluation of androgen receptors in genital and extragenital lichen sclerosus: Evidence for loss of androgen receptors in lesional epidermis. J Am Acad Dermatol 41: 43–46
Connor R, Braunstein B (1987) Hyperpigmentation following the use of bleaching creams. Arch Dermatol 123: 105
Conti CM, Leengoed H van, Dozier SE, Shanler SD, Whitaker JE, Sommer C, Barcos M, Stoll HL, Oseroff AR (1995) Photodynamic therapy with delta-aminolevulinic acid for the treatment of cutaneous T-cell lymphoma (CTCL). Proc Am Assoc Cancer Res 36: 609
Colararino R, Dubost JJ, Brun P, Flori B, Tournilhac M, Eschalier A, Sauvezie B (1990) États polyalgiques induits par le minoxidil topique. Ann Med Interne 141: 425–428
Dillaha CJ, Jansen T, Honeycutt MW (1965) Further studies with topical 5-fluorouracil. Arch Dermatol 92: 410–417
Dutrée-Meulenberg ROGM, Nieboer C, Koedijk HFJ, Stolz E (1988) Treatment of male pattern alopecia using topical mionoxidil in the Netherlands. Int J Dermatol 27: 435–440
Eaglstein WH, Weinstein GD, Frost P (1970) Fluorouracil: mechanism of action in human skin and actinic keratoses. Arch Dermatol 101: 132–139
Ebner H, Müller E (1995) Allergic contact dermatitis from minoxidil. Contact Dermatitis 32: 316–317
Eich D, Eich HT, Otte HG, Ghilescu V, Stadler R (1999) Photodynamische Therapie kutaner T-Zell-Lymphome in besonderer Lokalisation. Hautarzt 50: 109–114
Eller MG, Szpunar GJ, Della-Coletta AA (1989) Absorption of minoxidil after topical application: effect of frequency and site of application. Clin Pharmacol Ther 45: 396–402
Epstein E (1969) Treatment of precancerous dermatoses with topical 5-fluorouracil. Asth Med 18: 153–156
Epstein E (1998) Does intermittent“ pulse” topical 5 - fluorouracil therapy allow destruction of actinic keratoses without significant inflammation? J Am Acad Dermatol 38: 77–80
Falabella AF, Carson P, Eaglstein W, Falanga V (1998) The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol 39: 737–740
Ferry JJ, Forbes KK, Vanderlugt JT, Szpunar GJ (1990a) Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution. Clin Pharmacol Ther 47: 439–446
Ferry JJ, Shepard JH, Szpunar GJ (1990b) Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution. J Pharmaceut Sci 79: 483–486
Fiedler-Weiss VC, Buys CM (1987) Response of severe alopecia areata correlates with T lympho-cytes stimulation. Br J Dermatol 117: 759–763
Final report on the safety assessment of panthenol and pantothenic acid (1987). J Am Coll Toxicol 6: 139–161
Fischer E (1981) Dyschromia in confetti: Eine chemisch induzierte Leukodermie. Akt Dermatol 7: 46
Fischer H, Gilliet F, Hornemann M, Leyh F, Lindemayer H, Stegmann W, Welke S (1984) En-zymatische Wundreinigung beim venösen Ulcus cruris - Bericht über eine multizentrische klinische Vergleichsstudie mit verschiedenen Enzympräparaten. Fortschr Med 102: 281–283
Fisher AA (1998) The safety of bleaching creams containing hydroquinone. Cutis 61: 303–304
Franz ThJ (1985) Percutaneous absorption of minoxidil in man. Arch Dermatol 121: 203–206
Fritsch C, Stege H, Saalmann G, Goerz G, Ruzicka T, Krutmann J (1997) Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photoder-matol Photoimmunol Photomed 13: 181–185
Garbe C, Reimann H, Sander-Bähr C (1996) Rationelle dermatologische Rezeptur. Thieme Verlag-Govi Verlag, S 219
Girard P, Beraud A, Goujon C, Sirvent A, Foyatier JL, Allearme B, de Bony R (1998) Effect of bepanthen ointment on the graft - donor site wound healing model: a double blind biometrical and clinical study with assessment by the patient versus the vehicle. Nouv Dermatol 17: 559–570
Gehring W, Gloor M (1999) Neue Aspekte zur Modulation einer reduzierten epidermalen Barrierefunktion. Z Hautkr 74: 530
Gloor M, Hübscher M, Friederich HC (1974) Untersuchungen zur externen Behandlung der Akne vulgaris mit Tetracyclinen und Östrogen. Hautarzt 25: 391–394
Goette DK (1981) Topical chemotherapy with 5 - fluorouracil - a review. J Am Acad Dermatol 4: 633–649
Grob M, Schmid-Grendelmeier P (1998) Topische photodynamische Therapie in der Dermatologie. Ther Umsch 55: 529–532
Harth Y, Hirshowitz B, Kaplan B (1998) Modified topical photodynamic therapy of superficial tumors, utilizing aminolevulinic acid, penetration enhancers, red light and hyperthermia. Dermatol Surg 24: 723–726
Hauptmann S, Schäfer H, Fritz A, Hauptmann P (1992) Untersuchung der wachstumsbeeinflus-senden Wirkung von Wundsalben an der Zellkultur. Hautarzt 43: 432–435
Headington JT, Novak E (1984) Clinical and histologic studies of male pattern baldness treated with topical minoxidil. Curr Ther Res 36: 1098–1106
Hellgren L, Mohr V, Vincent J (1986) Proteases of antarctic krill - a new system for effective enzymatic debridement of necrotic ulcerations. Experientia 42: 403–404
Hursthouse MW (1975) A controlled trial on the use of topical 5 - fluorouracil on viral warts. Br J Dermatol 92: 93–96
Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JSt, Shull TF, Simpson KR, Bukaty LM (1997) Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. Arch Dermatol 133: 727–732
Jung W, Winter H (1998) Considerations for the use of clostridial collagenase in clinical practice. Clin Drug Invest 15: 245–252
Kapp A, Zeck-Kapp G (1991) Effect of Ca-pantothenate on human granulocyte oxidative metabolism. Allerg Immunol 37: 147–150
Karrer S, Szeimies RM, Hohenleutner U, Heine A, Landthaler M (1995) Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolevulinic acid. Dermatology 190: 218–222
Karrer S, Abels C, Szeimies RM, Bäumler W, Dellian M, Hohenleutner U, Goertz AE, Landthaler M (1996) Topical application of a first porphycene dye for photodynamic therapy-penetration studies in human perilesional skin and basal cell carcinoma. Arch Dermatol Res 289: 132–137
Kennedy JC, Pottier RH (1992) Endogenous protoporphyrin IX, a clinically useful photosentized for photodynamic therapy. J Photochem Photobiol B 14: 275
Khoury EL, Price VH, Abdel-Salam MM, Stern M, Greenspan JS (1992) Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration. J Invest Dermatol 99:40–47
Kligman AM, Willis I (1975) A new formula for depigmenting human skin. Arch Dermatol 111: 40–48
Koperski JA, Orenberg EK, Wilkinson DI (1987) Topical minoxidil therapy for androgenetic alopecia. Arch Dermatol 123: 1483–1487
Krebs HB (1987) The use of topical 5 - fluorouracil in the treatment of genital condylomas. Obstet Gynecol Clin North Am: 14: 559–568
Kreindler ThG (1987) Topical minoxidil in early androgenetic alopecia. J Am Acad Dermatol 16: 718–724
Lascano EF, Montes LF, Mazzini MA (1964) Lichen sclerosus et atrophicus in childhood-report of 6 cases. Obstet Gynaecol 24: 872–877
Leenen FHH, Smith DL, Unger WP (1988) Topical minoxidil: cardiac effects in bald man. Br J Clin Pharmacol 26: 481–485
Lewenberg A (1996) Minoxidil-tretinoin combination for hair regrowth: effects of frequency, dosage, and mode of application. Adv Therap 13: 274–283
López-Bran E, Robledo A, Aspiolea F, Morágas JM, Quintanilla E, Sambrico F, Pino J del (1990) Multicentre comparative study of the efficacy of topical 2% minoxidil (regaine) versus placebo in the treatment of male baldness. Adv Therap 7: 159–168
Mekkers JR, Le Poole IC, Dar PK, Bos JD, Westerhof W (1998) Efficient debridement of necrolytic wounds using proteolytic enzymes derived from antarctic krill: a double-blind, placebo-con-trolled study in a standardized animal wound model. Wound Rep Reg 6: 50–58
Mezei M (1994) Topical drug delivery by liposomal encapsulation. J Pharm Sci 83: 1202
Mills OH, Kligman AM (1978) Further experience with a topical cream for depigmenting human skin. J Soc Cosm Chem 29: 147–154
Nuck BA, Fogelson StL, Lucky AW (1987) Topical minoxidil does not act as an antiandrogen in the flank organ of the golden Syrian hamster. Arch Dermatol 123: 59–61
Oakley A M M (1996) Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone. Austr J Dermatol 37: 96–98
Olsen EA, De Long ER, Weiner MS, Durham BSN (1987) Long term follow-up of men with male pattern baldness treated with topical minoxidil. J Am Acad Dermatol 16: 688–695
Olsen EA, Weiner MS, Amara IA, De Long ER (1990) Five year follow up of men with andro-genetic alopecia treated with topical monoxidil. J Am Acad Dermatol 22: 643–646
Orfanos CE (1990) Androgenic Alopecia: clinical aspects and treatment In: Orfanos CE, Happle R (Hrsg). Hair and Hair Diseases. G Fischer, Stuttgart New York, S 485–527
Palumbo A, Ischia M, Misurca G, Prota G (1992) Skin depigmentation by hydroquinone: a chemical and biochemical insight. Pigment Cell Res Suppl 2: 299–303
Parker LU, Bergfeld WF (1991) Virilization secondary to topical testosterone. Cleve Clin J Med 58: 43–46
Pasieczny TAH (1977) The treatment of balanitis xerotica obliterans with testosterone propionate ointment. Acta Derm Venereol (Stockh) 57: 275–277
Pathak MA, Fitzpatrick Th B, Kraus EW (1986) Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol 15: 894–899
Pearlman DL (1991) Weekly pulse dosing: effective and comfortable topical 5 - fluorouracil treat-ment of multiple facial actinic keratoses. J Am Acad Dermatol 25: 665–667
Peluso AM, Misciali C, Vincenzi C, Tosti A (1997) Diffuse hypertrichosis during treatment with 5% topical minoxidil. Br J Dermatol 136: 118–120
Penney KB, Smith CJ, Allen JC (1984) Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J Invest Dermatol 82: 308–310
Petzoldt D and the German topical Minoxidil Study Group (1988) The german double-blind placebo-controlled treatment of early male pattern baldness. Int J Dermatol Suppl 27: 430–434
Piepkorn MW, Weidner M (1988) Comparable efficacy of 2% minoxidil gel and solution for-mulations in the treatment of male pattern alopecia. J Am Acad Dermatol 18: 1059–1062
Price H (1987) Double-blind, placebo controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol 16: 730–736
Pugliese PT, Farina JC, Chautems Y (1995) Efficacy of dexpanthenol in wound healing: a double-blind assessment of excised wound tissue by ultrasound and histologic examination. Nouv Dermatol 14: 130–138
Roberts JL (1987) Androgenetic alopecia: treatment results with topical minoxidil. J Am Acad Dermatol 16: 705–710
Rosseeuw DI and the Belgian Topical Minoxidil Study Group (1988) The Belgian Ten-Center open label trial of topical 2% minoxidil solution in early male pattern alopecia. Int J Dermatol Suppl 27: 452–455
Sakita S, Morohashi M (1996) The effect of minoxidil on the proliferation of follicular capillaries in vivo. Acta Dermatol Kyoto 91: 507–509
Sander ChA, Pfeiffer Ch, Kligman AM, Plewig G (1997) Chemotherapy for disseminated actinic keratoses with 5 - fluorouracil and isotretinoin. J Am Acad Dermatol 36: 236–238
Schramm P (1989) Klinische Erfahrungen mit Kollagenase Puder bei Ulcera unterschiedlicher Genese - Eine Doppelblindstudie über Iruxol mono Puder. Akt Dermatol 15: 146–149
Schuhmacher-Stock U, Winkler K (1977) Die externe Östrogentherapie der androgenetischen Alopecie. Hautarzt Suppl 2: 336–338
Schulze-Dirks A, Frosch PJ (1988) Kontaktallergie auf Dexpanthenol. Hautarzt 39: 375–377
Senff H, Reinel D, Matthies, Witts D (1988) Topical 5-fluorouracil solution in the treatment of warts-clinical experience and percutaneous absorption. Br J Dermatol 118: 409–414
Shapiro J, Ran J, Ho V, Abbot F, Tron V (1993) Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. J Am Acad Dermatol 29: 729–735
Sheretz EF, Sloan KB (1987) Penetration flux of commercial topical 5 - fluorouracil preparations through hairless mouse and human skin in vitro. Clin Res 35: 717A
Sitruk-Ware R (1994) Percutaneous and transdermal oestrogen replacement therapy. Ann Med 25: 77–82
Soler AM, Warloe T, Tausj, Berner A (1999) Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and currettage in nodular basal cell carcinoma: a one-year follow up study. Acta Derm Venereol (Stockh) 79: 204–206
Strauss JS (1963) Hormones in cosmetics. JAMA 186: 759–762
Strauss JS (1981) Hormones and the pilosebaceous apparatus. In: Orfanos CE, Montagna W, Stüttgen G (eds). Hair Research-Status and Future Aspects. Springer Verlag, Heidelberg, PP 223–228
Stüttgen G, Krause H (1960) Die percutane Absorption von tritium-markiertem Panthenol bei Mensch und Tier. Arch Klin Exp Dermatol 209: 578–582
Suomalainen O (1983). Evaluation of two enzyme preparations - trypure and varidase in traumatic ulcers. Annal Chir Gynaecol 72: 62–65
Szeimies RM, Karrer S, Sauerwald A, Landthaler M (1996) Photodynamic therapy with topical application of 5 - aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 192: 246–251
Tata S, Flynn GL, Weiner ND (1995) Penetration of minoxidil from ethanol/propylene glycol solutions: effect of application volume and occlusion. J Pharm Sci 84: 688–691
Tata S, Weiner N, Flynn G (1994a) Relative influence of ethanol and propylene glycol cosolvents on desposition of minoxidil into the skin. J Pharmac Sci 83: 1508–1510
Tata S, Weiner N, Flynn G (1994b) Penetration of minoxidil through the skin from ethanol/propylenglycol solutions: effect of application volume. Pharm Res Suppl 11: S 188
Thiele B, Grotmann P, Hüttmann G, Diddens H, Hörauf H (1994) Topische photodynamische Therapie (TPDT) von Basaliomen: Klinische, histologische und experimentelle Ergebnisse (erste Mitteilung). Z Hautkr 69: 161–165
Tosti A (1986) Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases. Dermatologica 173: 136–138
Trattner A, Inber A (1992) Topical treatment with minoxidil 2% and smoking intolerance. Ann Pharmacother 26: 198–199
Tsai JC, Flynn GL, Weiner N, Ferry JJ (1994a) Influence of application time and formulation reapplication on the delivery of minoxidil through hairless mouse skin as measured in Franz diffusion cells. Skin Pharmacol 7: 270–277
Tsai JC, Weiner N, Flynn GL, Ferry JJ (1994b) Drug and vehicle deposition from topical applications: localization of minoxidil within skin strata of the hairless mouse. Skin Pharmacol 7: 262–269
Uno H, Cappas A, Brigham P (1985) Increased DNA synthesis of the hair follicular and perifollicular cells by topical minoxidil in the macaque scalp. Clin Res 33: 692 A
Uno H, Mori O, Cappas A, Buys CM, Fiedler Weiss V (1986) The effect of topical minoxidil on sequential histological changes in alopecia totalis and universalis. J Invest Dermatol 86: 512
Usami Y, Landau AB, Fukuyama K, Gellin GA (1980) Inhibition of thyrosinase activity by 4- tert-butylcatechol and other depigmenting agents. J Toxicol Environm Health 6: 559–567
Vaillant L, Callens A (1996) Traitement hormonal substitutif et vieillissement cutané. Thérapie 51: 67–70
Valeriote F, Santelli G (1984) 5 Fluorouracil (FUra). Pharmacol Ther 24: 107–132
Vanderveen EE (1985) The effect of topical minoxidil on blood pressure reply. J Am Acad Dermatol 13: 673–674
Weiser H, Erlemann A (1987) Beschleunigte Heilung oberflächlicher Wunden durch Panthenol und Zinkoxid. Parf Kosm 68: 425–427
Wester RC, Maibach HI, Guy RH, Novak E (1984) Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser velocimetry and photopulse plethysmography. J Invest Dermatol 82: 515–517
Wester RC, Melendres J, Hui X, Cox R, Serranzana S, Zhai H, Quan D, Maibach HI (1998) Human in vivo and in vitro hydroquinone topical bioavalilability metabolism and disposition. J Toxicol Environm Health Part A 54: 301–317
Westerhof W, Jansen FC, Wit FS de, Cormane RH (1987) Controlled double-blind trial of fibrinolysin-desoxyribonuclease (elase) solution in patients with chronic leg ulcers who are treated before autologous skin grafting. J Am Acad Dermatol 17: 32–39
Wettach A (1953) Förderung der Epithelisierung von Hautwunden mit Pantothensäure beim Pferd. Inaugural-Dissertation, Zürich
Willigen AH van der, Dutrée-Meulenberg OGM, Stolz E, Geursen-Reitsma AM, Joost Th van (1987) Topical minoxidil sentization in androgenetic alopecia. Contact Dermatitis 17: 43–44
Wokalek H (1992) Pigmentierungs-und Bleichmittel In: Niedner R, Ziegenmeyer J (Hrsg). Dermatika, Therapeutischer Einsatz, Pharmakologie und Pharmazie. Wissenschaftl. Verlagsgesellschaft, Stuttgart, S 167–171
Wolf P (1997) Photodynamische Therapie. Hautarzt 48: 137–148
Wolf P, Rieger E, Kerl H (1993) Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid J Am Acad Dermatol 28: 17–21
Wolf P, Fink-Puches R, Reimann-Weber A, Kerl H (1997) Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. Dermatology 194: 53–54
Wüstner H, Orfanos CE (1974) Alopecia androgenetica und ihre Lokalbehandlung mit östrogenund corticoidhaltigen Externa. Z Hautkr 49: 879–888
Zelickson AS, Mottaz J, Weiss LW (1975) Effects of topical fluorouracil on normal skin. Arch Dermatol 111: 1301–1306
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gloor, M. (2000). Sonstige Wirkstoffe. In: Dermatologische Externatherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58308-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-58308-7_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63533-5
Online ISBN: 978-3-642-58308-7
eBook Packages: Springer Book Archive